Hip Arthroscopy with Periacetabular Osteotomy for Hip Dysplasia
Trial Summary
What is the purpose of this trial?
The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Periacetabular osteotomy combined with hip arthroscopy for hip dysplasia?
Research shows that the Bernese periacetabular osteotomy (PAO) is effective for treating hip dysplasia by reorienting the hip socket, and combining it with hip arthroscopy can address additional hip joint issues. Studies have reported positive intermediate-term outcomes and patient satisfaction with this combined approach.12345
Is hip arthroscopy with periacetabular osteotomy generally safe for humans?
Periacetabular osteotomy (PAO), including its combination with hip arthroscopy, is generally considered safe, but there are some risks. Studies have reported complications such as femoroacetabular impingement (a condition where bones in the hip joint rub against each other) and other surgical risks, which can vary based on the surgical approach used.12678
How does the treatment of hip arthroscopy with periacetabular osteotomy for hip dysplasia differ from other treatments?
This treatment is unique because it combines hip arthroscopy (a minimally invasive procedure to look inside the joint) with periacetabular osteotomy (a surgery to correct the hip socket's position) to address both the bone structure and any joint issues in patients with hip dysplasia, offering a comprehensive approach to treatment.13459
Research Team
Rafael Sierra, MD
Principal Investigator
Mayo Clinic
Eligibility Criteria
This trial is for individuals aged 15-55 with hip dysplasia, specifically Developmental Dysplasia of the Hip (DDH), who are skeletally mature and have minimal or no arthritis. They must be able to undergo a preoperative MRI arthrogram of the hip. Pregnant women, those with previous hip surgeries, or patients treated for acetabular retroversion without DDH cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgery
Participants undergo periacetabular osteotomy with or without hip arthroscopy
Follow-up
Participants are monitored for safety and effectiveness after surgery
Treatment Details
Interventions
- Periacetabular osteotomy
- Periacetabular osteotomy with hip arthroscopy
Periacetabular osteotomy is already approved in European Union, United States, Switzerland for the following indications:
- Hip dysplasia
- Developmental dysplasia of the hip (DDH)
- Femoroacetabular impingement (FAI)
- Hip dysplasia
- DDH
- FAI
- Labral tears
- Hip dysplasia
- DDH
- FAI
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor